SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-24-030994
Filing Date
2024-03-05
Accepted
2024-03-05 16:05:07
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1 tm245173-7_s1.htm S-1 785210
2 EXHIBIT 1.1 tm245173d4_ex1-1.htm EX-1.1 302767
3 EXHIBIT 5.1 tm245173d4_ex5-1.htm EX-5.1 8177
4 EXHIBIT 23.1 tm245173d4_ex23-1.htm EX-23.1 2382
5 EX-FILING FEES tm245173d4_ex-filingfees.htm EX-FILING FEES 12547
6 GRAPHIC tm245173d4_ex5-1img001.jpg GRAPHIC 9317
7 GRAPHIC lg_apogeetherapeutics-4c.jpg GRAPHIC 60691
  Complete submission text file 0001104659-24-030994.txt   1208995
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-277664 | Film No.: 24720233
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)